KDKhalid Bin Dhuban

Khalid Bin Dhuban

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khalid Bin Dhuban has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Ciriaco A. Piccirillo

    Department of Microbiology and Immunology, McGill University, Montréal, Québec, Canada

    5 shared publications
  • Bruce Mazer

    Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, McGill University Health Center, Montréal, Québec H3H 1P3, Canada

    2 shared publications
  • Eva D'HEnnezel

    Department of Microbiology and Immunology and FOCIS Center of Excellence McGill University and the Research Institute

    2 shared publications
  • Moshe Ben-Shoshan

    Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, McGill University Health Center, Montréal, Québec H3H 1P3, Canada

    2 shared publications
  • Alan Berezov

    Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-6082, USA

    1 shared publication
  • Amit Bar-Or

    Neuroimmunology Unit, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec H3A 2B4, Canada

    1 shared publication

Latest Publications

  • Suppression by human FOXP3 + regulatory T cells requires FOXP3-TIP60 interactions

    by Khalid Bin Dhuban, Eva D’hEnnezel, Yasuhiro Nagai, Yan Xiao, Steven Shao, Roman Istomine, Fernando Alvarez, Moshe Ben-Shoshan, Hans Ochs, Bruce Mazer, et al.

    Targeting the FOXP3-TIP60 interaction may modulate T reg activity in IPEX and other autoimmune and inflammatory diseases.


  • The immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome

    by Khalid Bin Dhuban, Ciriaco A. Piccirillo

    This article presents a comprehensive review of the immunodysregulation, polyendocrinopathy, enteropathy and X-linked (IPEX) syndrome, covering both the clinical and molecular aspects of the disease. (Figure is included in full-text article.) The IPEX syndrome is a rare immunological disorder in humans caused by inheritable mutations in the FOXP3 gene, the master transcriptional regulator for the development and function of CD4 regulatory T (Treg) cells. Forkhead box protein 3 (FOXP3) Treg cells represent a unique T-cell lineage with inhibitory functions, and are responsible for immune homeostasis and tolerance to self and nonself antigens. Evidence shows that a Treg developmental deficiency or dysfunction underlies the severe, multiorgan, autoimmune disease of IPEX. An in-depth structural and functional analysis of the molecular domains of FOXP3 is essential for our understanding of the observed clinical heterogeneity and prognosis in IPEX.


  • Molecular Genetics of the IPEX Syndrome

    by Khalid Bin Dhuban, Ciriaco A Piccirillo

  • Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells

    by Khalid Bin Dhuban, Eva D’hennezel, Emil Nashi, Amit Bar-Or, Sadiye Rieder, Ethan M. Shevach, Satoshi Nagata, Ciriaco A Piccirillo

    Two distinct subsets of CD4+Foxp3+ regulatory T (Treg) cells have been described based on the differential expression of Helios, a transcription factor of the Ikaros family. Efforts to understand the origin and biological roles of these Treg populations in regulating immune responses have, however, been hindered by the lack of reliable surface markers to distinguish and isolate them for subsequent functional studies. Using a single-cell cloning strategy coupled with microarray analysis of different Treg functional subsets in humans, we identify the mRNA and protein expression of TIGIT and FCRL3 as a novel surface marker combination that distinguishes Helios+FOXP3+ from Helios−FOXP3+ memory cells. Unlike conventional markers that are modulated on conventional T cells upon activation, we show that the TIGIT/FCRL3 combination allows reliable identification of Helios+ Treg cells even in highly activated conditions in vitro as well as in PBMCs of autoimmune patients. We also demonstrate that the Helios−FOXP3+ Treg subpopulation harbors a larger proportion of nonsuppressive clones compared with the Helios+FOXP3+ cell subset, which is highly enriched for suppressive clones. Moreover, we find that Helios− cells are exclusively responsible for the productions of the inflammatory cytokines IFN-γ, IL-2, and IL-17 in FOXP3+ cells ex vivo, highlighting important functional differences between Helios+ and Helios− Treg cells. Thus, we identify novel surface markers for the consistent identification and isolation of Helios+ and Helios− memory Treg cells in health and disease, and we further reveal functional differences between these two populations. These new markers should facilitate further elucidation of the functional roles of Helios-based Treg heterogeneity.


  • Functional dynamics of Foxp3+ regulatory T cells in mice and humans

    by Khalid Bin Dhuban, Mara Kornete, Edward S. Mason, Ciriaco A. Piccirillo

    Summary: Forkhead box protein 3 (Foxp3)+ regulatory T (Treg) cells are critical mediators for the establishment of self‐tolerance and immune homeostasis and for the control of pathology in various inflammatory responses. While Foxp3+ Treg cells often control immune responses in secondary lymphoid tissues, they must also traffic to and persist within non‐lymphoid tissues, where they integrate various environmental cues to coordinate and adapt their effector acitvities in these sites. In recent years, our group has made use of several mouse models, including the non‐obese diabetic model of type 1 diabetes, to characterize the factors, which impact the homeostasis, function, and reprogramming potential of Foxp3+ Treg cells in situ. In addition, our recent work shows that Foxp3+ Treg cells possess distinct post‐transcriptional mechanisms of gene regulation, namely mRNA translation, to modulate tissue‐specific inflammatory responses. In humans, there is a pressing need for reliable markers of FOXP3+ Treg cells and their related function in blood and tissue. Experimental progress in our group has enabled us to discover novel markers of FOXP3+ Treg cell (dys)function and unique gene signatures that discriminate effector and Treg cells, as well as functional and dysfunctional FOXP3+ Treg cells.


  • Open Access

    Altered T Helper 17 Responses in Children with Food Allergy

    by Khalid Bin Dhuban, Eva D'HEnnezel, Moshe Ben-Shoshan, Christine McCusker, Ann Clarke, Pierre Fiset, Bruce Mazer, Ciriaco A. Piccirillo

    Background: While a central role for the T helper (Th) 1/Th2 axis in food allergy has been established, the Th17 response in food-allergic humans has not been addressed. Methods: Th17 responses in 18 peanut-allergic children, who were also allergic to at least one additional food allergen, were assessed relative to 15 age-matched healthy controls. To account for the atopy background in the allergic children, 7 atopic, but not food-allergic, individuals and their age-matched controls were included in this study. PBMCs were analyzed by flow cytometry ex vivo or were stimulated in vitro with peanut allergens, gliadin, or tetanus toxoid followed by analysis of proliferation and cytokine production in antigen-responsive cells. Results: We observed a significantly lower interleukin (IL) 17 production in CD4+ T cells of food-allergic individuals ex vivo (p < 0.02). In vitro, we found that IL-17 production in CD4+ T cells in response to all antigens tested was significantly impaired in food-allergic subjects compared to healthy controls (Ara: p < 0.005; gliadin: p < 0.004; TT: p < 0.03). No significant differences were observed between atopic and nonatopic individuals with no food allergy. Conclusion: Our results thus reveal a systemic, non-allergen-specific defect in Th17 responses to antigen stimulation in food allergic individuals, suggesting a role for Th17 cells in the control of food allergy and implicating IL-17 as a potential biomarker for tolerance to food antigens.


  • The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

    by Eva D'HEnnezel, Khalid Bin Dhuban, Troy Torgerson, Ciriaco Piccirillo

    Immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome is a rare disorder in humans caused by germ-line mutations in the FOXP3 gene, a master transcriptional regulator for the development of CD4 regulatory T (Treg) cells. This T cell subset has global inhibitory functions that maintain immune homeostasis and mediate self-tolerance. Treg developmental deficiency or dysfunction is a hallmark of IPEX. It leads to severe, multi-organ, autoimmune phenomena including enteropathy, chronic dermatitis, endocrinopathy and other organ-specific diseases such as anaemia, thrombocytopenia, hepatitis and nephritis. In this review, the genetic, immunological and clinical characteristics of IPEX syndrome are described, and the impact of heritable mutations on the function of Treg cells highlighted.


  • Acquired Omenn-Like Syndrome, a Novel Posttransplant Autoaggression Syndrome Reversed by Rapamycin

    by Donald C. Vinh, Khalid Bin Dhuban, Helen Mason, Duncan Lejtenyi, SungMi Jung, Donald C. Sheppard, Damien Faury, Nada Jabado, Ciriaco A. Piccirillo

    Graft-versus-host disease is uncommon in autologous hematopoietic cell transplantation (HCT) and is typically brief and mild. We report unusual, protracted, and severe Omenn syndrome-like autoaggression following autologous HCT. We identified a profound FOXP3 + regulatory T cell defect that coincided with hyperinflammatory T cell responses which were reversible with rapamycin in vitro .